Childhood Hematopoietic and Lymphatic System Neoplasm

Childhood Hematopoietic and Lymphatic System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

570 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03245424	Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation	approved for marketing	—	—	Agios Pharmaceuticals, Inc.INDUSTRY	0	Jul 24, 2018	clinicaltrials
NCT01869803	Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia	approved for marketing	—	—	Wake Forest University Health SciencesOTHER	1	Mar 2, 2018